U.S. supreme court decision paves way for better genetic testing: Ruling bars exclusive licensing, patents on naturally occurring genes

American Journal of Medical Genetics, Part A

Volumn 161, Issue 9, 2013, Pages

  Levenson, Deborah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

DIAGNOSTIC TEST; DNA DETERMINATION; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOME ANALYSIS; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; JURISPRUDENCE; LAW SUIT; NOTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UNITED STATES;

GENES; GENETIC TESTING; HUMANS; PATENTS AS TOPIC; SUPREME COURT DECISIONS; UNITED STATES;

EID: 84881627484     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36167     Document Type: Note

References (1)

1. American College of Medical Genetics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. http://www.acmg.net/AM/Template.cfm?Section=Home3. Published March 21, 2013.